NPI: 1104217918 · DELTONA, FL 32725 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 02/16/2015
Authorized official WEY, SAMUEL controls 20+ related entities in our dataset. Read more
| Authorized Official | WEY, SAMUEL (VP, LICENSURE & CERTIFICATION) |
| NPI Enumeration Date | 02/16/2015 |
Other providers sharing the same authorized official: WEY, SAMUEL
| Provider | City | State | Total Paid |
|---|---|---|---|
| DVA HEALTHCARE RENAL CARE INC | NORTH HOLLYWOOD | CA | $16.47M |
| DVA HEALTHCARE RENAL CARE INC | DELANO | CA | $16.43M |
| DVA RENAL HEALTHCARE INC | LOS ANGELES | CA | $15.51M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $14.93M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.67M |
| DVA RENAL HEALTHCARE INC | OAKLAND | CA | $13.42M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.25M |
| DVA HEALTHCARE RENAL CARE INC | YUMA | AZ | $12.88M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $12.77M |
| DVA RENAL HEALTHCARE INC | FULLERTON | CA | $12.19M |
| DVA HEALTHCARE RENAL CARE INC | POMONA | CA | $11.96M |
| DVA RENAL HEALTHCARE INC | ANAHEIM | CA | $11.32M |
| DVA RENAL HEALTHCARE INC | ESCONDIDO | CA | $10.94M |
| DVA HEALTHCARE RENAL CARE INC | COSTA MESA | CA | $10.08M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $9.46M |
| DVA RENAL HEALTHCARE INC | VISALIA | CA | $9.22M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $8.83M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $8.56M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $7.78M |
| DVA RENAL HEALTHCARE INC | PALM SPRINGS | CA | $7.48M |
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 9,592 | $1.38M |
| 2019 | 17,534 | $2.64M |
| 2020 | 21,868 | $3.01M |
| 2021 | 18,136 | $1.56M |
| 2022 | 11,838 | $2.46M |
| 2023 | 3,575 | $538K |
| 2024 | 1,831 | $120K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 90999 | Unlisted dialysis procedure, inpatient or outpatient | 32,859 | 1,974 | $5.08M |
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 24,365 | 1,210 | $2.98M |
| J1270 | Injection, doxercalciferol, 1 mcg | 10,663 | 665 | $1.16M |
| A4657 | Syringe, with or without needle, each | 2,681 | 1,156 | $599K |
| J1756 | Injection, iron sucrose, 1 mg | 3,976 | 818 | $455K |
| 85041 | 1,617 | 1,070 | $238K | |
| 85048 | 1,571 | 1,044 | $230K | |
| 83970 | 1,175 | 789 | $202K | |
| 82728 | 1,149 | 763 | $173K | |
| 83550 | 1,123 | 743 | $163K | |
| 83540 | 1,128 | 743 | $163K | |
| 85045 | 935 | 589 | $94K | |
| 82108 | 440 | 288 | $61K | |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 278 | 155 | $36K |
| J2501 | Injection, paricalcitol, 1 mcg | 184 | 12 | $32K |
| 82607 | 96 | 69 | $15K | |
| 82746 | 90 | 59 | $13K | |
| 90674 | 21 | 16 | $5K | |
| G0008 | Administration of influenza virus vaccine | 23 | 17 | $4K |